With its announcement of nine more centers receiving Pulmonary Hypertension Care Center (PHCC) accreditation bringing the total to 26, the Pulmonary Hypertension Association (PHA) is hopeful as it seeks to improve overall care and outcomes for people with pulmonary hypertension (PH).
PH, specifically pulmonary arterial hypertension (PAH), is a rare and debilitating disease of the lungs that affects the functioning of the heart and can lead to right heart failure.
The nine newly accredited PHCCs are:
- Froedtert and Medical College of Wisconsin Pulmonary Hypertension Service at Froedtert Hospital and the Medical College of Wisconsin – Milwaukee, Wisc
- Johns Hopkins Pulmonary Hypertension Program at Johns Hopkins University – Baltimore, Md
- University of California, San Francisco (UCSF) Pulmonary Hypertension Program at the University of California, at San Francisco Medical Center—San Francisco, Calif
- UCSF Pediatric Pulmonary Hypertension Program at UCSF Benioff Children’s Hospital at UCSF Medical Center – San Francisco, Calif
- Pulmonary Hypertension Clinical Program at Mayo Clinic Florida, Jacksonville, Fla
- Pulmonary Hypertension Program at the University of Iowa, Heart and Vascular Center – Iowa City, Iowa
- The University of Kansas Pulmonary Hypertension Program at The University of Kansas Hospital – Kansas City, Kan
- University of North Carolina Pulmonary Hypertension Program at the University of North Carolina at Chapel Hill/UNC Hospitals – Chapel Hill, NC
- Pulmonary Vascular Disease Program, Center for Pulmonary Heart Disease, Brigham and Women’s Hospital, and Harvard Medical School – Boston, Mass.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management